Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Semin Radiat Oncol. 2012 Jan;22(1):18-28. doi: 10.1016/j.semradonc.2011.09.004.

What we have learned: the impact of quality from a clinical trials perspective.

Author information

  • Department of Radiation Oncology, UMass Memorial Healthcare, University of Massachusetts Medical School, Worcester, MA, USA. TJFitzGerald@QARC.org

Abstract

In this review article, we address the radiation oncology process improvements in clinical trials and review how these changes improve the quality for the next generation of trials. In recent years, we have progressed from a time of limited data acquisition to the present in which we have real-time influence of clinical trials quality. This enables immediate availability of the important elements, including staging, eligibility, response, and outcome for all trial investigators. Modern informatics platforms are well designed for future adaptive clinical trials. We review what will be needed in the informatics architecture of current and future clinical trials.

Copyright © 2012 Elsevier Inc. All rights reserved.

PMID:
22177875
[PubMed - indexed for MEDLINE]
PMCID:
PMC3244686
Free PMC Article

Images from this publication.See all images (6)Free text

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Write to the Help Desk